A critical discovery in cancer investigation is arising with the use of nanobodies to re-engage dysfunctional p53. This crucial cancer suppressor protein is frequently inactivated in many types of tumors, resulting https://keybookmarks.com/story21970444/nanobodies-reactivate-tumor-suppressor-p53-a-new-pathway-for-tumor-treatment